John J. Chipman

2.5k total citations
34 papers, 1.8k citations indexed

About

John J. Chipman is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, John J. Chipman has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 15 papers in Genetics. Recurrent topics in John J. Chipman's work include Growth Hormone and Insulin-like Growth Factors (20 papers), Sexual Differentiation and Disorders (15 papers) and Genetic Syndromes and Imprinting (6 papers). John J. Chipman is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (20 papers), Sexual Differentiation and Disorders (15 papers) and Genetic Syndromes and Imprinting (6 papers). John J. Chipman collaborates with scholars based in United States, Chile and United Kingdom. John J. Chipman's co-authors include Brenda Crowe, Charmian A. Quigley, Mark L. Hartman, Beverly M. K. Biller, Gordon B. Cutler, Judith L. Ross, Werner Blum, David R. Clemmons, Ken K. Y. Ho and Andrea Attanasio and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Hypertension.

In The Last Decade

John J. Chipman

34 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John J. Chipman United States 19 1.4k 578 562 391 322 34 1.8k
P Rochiccioli France 25 1.0k 0.7× 512 0.9× 562 1.0× 474 1.2× 158 0.5× 111 1.7k
MB Ranke Germany 22 861 0.6× 554 1.0× 601 1.1× 291 0.7× 212 0.7× 62 1.4k
G. Massa Belgium 26 622 0.4× 772 1.3× 745 1.3× 343 0.9× 152 0.5× 77 1.8k
Catherine Dacou‐Voutetakis Greece 27 1.1k 0.8× 603 1.0× 759 1.4× 299 0.8× 231 0.7× 99 2.1k
Berit Kriström Sweden 24 965 0.7× 454 0.8× 515 0.9× 473 1.2× 255 0.8× 61 1.6k
Giorgio Radetti Italy 28 1.3k 0.9× 616 1.1× 525 0.9× 314 0.8× 88 0.3× 90 2.4k
Margaret H. MacGillivray United States 28 1.0k 0.7× 517 0.9× 531 0.9× 324 0.8× 108 0.3× 83 1.8k
K W Kastrup Denmark 18 878 0.6× 482 0.8× 349 0.6× 261 0.7× 159 0.5× 47 1.4k
Giorgio Radetti Italy 18 634 0.4× 319 0.6× 347 0.6× 249 0.6× 100 0.3× 57 1.2k
H Wollmann Germany 25 785 0.6× 766 1.3× 769 1.4× 1.0k 2.6× 131 0.4× 88 1.9k

Countries citing papers authored by John J. Chipman

Since Specialization
Citations

This map shows the geographic impact of John J. Chipman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Chipman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Chipman more than expected).

Fields of papers citing papers by John J. Chipman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Chipman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Chipman. The network helps show where John J. Chipman may publish in the future.

Co-authorship network of co-authors of John J. Chipman

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Chipman. A scholar is included among the top collaborators of John J. Chipman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Chipman. John J. Chipman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quigley, Charmian A., Anthony J. Zagar, David M. Brown, et al.. (2013). United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood. International Journal of Pediatric Endocrinology. 2013(1). 6–6. 18 indexed citations
2.
Hartman, Mark L., Rong Xu, Brenda Crowe, et al.. (2013). Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients. The Journal of Clinical Endocrinology & Metabolism. 98(3). 980–988. 68 indexed citations
3.
Ross, Judith L., Charmian A. Quigley, Dachuang Cao, et al.. (2011). Growth Hormone Plus Childhood Low-Dose Estrogen in Turner Syndrome. Obstetrical & Gynecological Survey. 66(8). 486–487. 3 indexed citations
4.
Ross, Judith L., Charmian A. Quigley, Dachuang Cao, et al.. (2011). Growth Hormone plus Childhood Low-Dose Estrogen in Turner's Syndrome. New England Journal of Medicine. 364(13). 1230–1242. 142 indexed citations
5.
Quigley, Charmian A., Anne Gill, Brenda Crowe, et al.. (2005). Safety of Growth Hormone Treatment in Pediatric Patients with Idiopathic Short Stature. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5188–5196. 69 indexed citations
6.
Attanasio, Andrea, Elena P. Shavrikova, Werner Blum, et al.. (2004). Continued Growth Hormone (GH) Treatment after Final Height Is Necessary to Complete Somatic Development in Childhood-Onset GH-Deficient Patients. The Journal of Clinical Endocrinology & Metabolism. 89(10). 4857–4862. 73 indexed citations
7.
Leschek, Ellen, Susan R. Rose, Jack A. Yanovski, et al.. (2004). Effect of Growth Hormone Treatment on Adult Height in Peripubertal Children with Idiopathic Short Stature: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 89(7). 3140–3148. 164 indexed citations
8.
Shalet, Stephen M., Elena P. Shavrikova, Christopher J. Child, et al.. (2003). Effect of Growth Hormone (GH) Treatment on Bone in Postpubertal GH-Deficient Patients: A 2-Year Randomized, Controlled, Dose-Ranging Study. The Journal of Clinical Endocrinology & Metabolism. 88(9). 4124–4129. 95 indexed citations
9.
Quigley, Charmian A., et al.. (2002). Growth Hormone and Low Dose Estrogen in Turner Syndrome: Results of a United States Multi-Center Trial to Near-Final Height. The Journal of Clinical Endocrinology & Metabolism. 87(5). 2033–2041. 118 indexed citations
10.
Hartman, Mark L., Brenda Crowe, Beverly M. K. Biller, et al.. (2002). Which Patients Do Not Require a GH Stimulation Test for the Diagnosis of Adult GH Deficiency?. The Journal of Clinical Endocrinology & Metabolism. 87(2). 477–485. 239 indexed citations
11.
Rose, Susan R., Jeffrey Baron, David Bernstein, et al.. (2000). Suppression and Recovery of GH Secretion after GH Injection in Non-GH Deficient Short Children. Journal of Pediatric Endocrinology and Metabolism. 13(3). 281–8. 6 indexed citations
12.
Chipman, John J., Andrea Attanasio, Martin Birkett, et al.. (1997). The safety profile of GH replacement therapy in adults. Clinical Endocrinology. 46(4). 473–481. 67 indexed citations
13.
Chipman, John J., et al.. (1995). Approaching Final Height in Children Treated for Growth Hormone Deficiency. Hormone Research. 43(4). 129–131. 9 indexed citations
14.
Chipman, John J.. (1993). Recent Advances in hGH Clinical Research. Journal of Pediatric Endocrinology and Metabolism. 6(3-4). 325–8. 3 indexed citations
15.
Chipman, John J.. (1993). Study Design for Final Height Determination in Turner Syndrome: Pros and Cons. Hormone Research. 39(2). 18–22. 6 indexed citations
16.
Chipman, John J., et al.. (1981). Interrelationship of Plasma and Urinary Gonadotropins: Correlations for 24 Hours, for Sleep/Wake Periods, and for 3 Hours after Luteinizing Hormone-Releasing Hormone Stimulation*. The Journal of Clinical Endocrinology & Metabolism. 52(2). 225–230. 12 indexed citations
17.
Buchanan, George R., et al.. (1981). Angiomatous lymphoid hamartoma: Inhibitory effects on erythropoiesis, growth, and primary hemostasis. The Journal of Pediatrics. 99(3). 382–388. 17 indexed citations
18.
Chipman, John J., Joseph E. Zerwekh, James F. Marks, & C. Y. C. Pak. (1980). Effect of growth hormone administration: Reciprocal changes in serum 1α,25-dihydroxyvitamin D and intestinal calcium absorption. Pediatric Research. 14. 1 indexed citations
19.
Chipman, John J., Joseph E. Zerwekh, Michael J. Nicar, James F. Marks, & Charles Y.C. Pak. (1980). Effect of Growth Hormone Administration: Reciprocal Changes in Serum lα,25-Dihydroxyvitamin D and Intestinal Calcium Absorption*. The Journal of Clinical Endocrinology & Metabolism. 51(2). 321–324. 57 indexed citations
20.
BOYAR, ROBERT M., et al.. (1978). Luteinizing Hormone and Follicle-Stimulating Hormone Secretory Dynamics in Turner's Syndrome*. The Journal of Clinical Endocrinology & Metabolism. 47(5). 1078–1083. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Rochiccioli Breakdown of academic impact, for papers by MB Ranke Breakdown of academic impact, for papers by G. Massa Breakdown of academic impact, for papers by Catherine Dacou‐Voutetakis Breakdown of academic impact, for papers by Berit Kriström Breakdown of academic impact, for papers by Giorgio Radetti Breakdown of academic impact, for papers by Margaret H. MacGillivray Breakdown of academic impact, for papers by K W Kastrup Breakdown of academic impact, for papers by Giorgio Radetti Breakdown of academic impact, for papers by H Wollmann
Rankless by CCL
2026